跳至主要内容
临床试验/NCT02774148
NCT02774148终止4 期

Pain Control in Elderly Hip Fracture Patients: Is Intravenous Acetaminophen Superior to Oral Administration?

Spectrum Health Hospitals1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2016年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
1
试验地点
1
主要终点
Pain Score

研究概览

简要总结

The primary objective is to determine if intravenous acetaminophen decreases pain scores and the amount of morphine equivalence received as compared to oral acetaminophen in patients greater than 65 years old after sustaining a hip fracture.

详细描述

Surgeons involved in this research agree to the randomization of patients into one of two groups. After informed consent, patients will be randomly assigned in a 1:1 ratio to the treatment group or the control group.

Group 1: This group will serve as the control group, and will be scheduled to receive one gram (1g) acetaminophen PO every 8 hours.

Group 2: This group will serve as the treatment group, and will be scheduled to receive one gram (1g) acetaminophen IV every 8 hours

The standardized pain control protocol for hip fracture patients will be initiated for all patients. The pain protocol will be initiated at hospital admission, and after three postoperative doses of the group assigned acetaminophen all patients will be switched to one gram scheduled acetaminophen PO in preparation for hospital discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute, isolated, unilateral femoral neck, intertrochanteric, and per trochanteric hip fractures confirmed by anteroposterior/lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI).
  • Age ≥ 65 years.
  • Low energy mechanism.
  • Hip fracture fixation performed within 48 hours of injury.
  • English speaking.
  • Anticipated medical optimization for operative fixation.
  • No other major trauma.

排除标准

  • Unable to provide informed consent (dementia, limited decision making capacity)
  • Admitted by medical service for significant co-morbidities
  • Retained hardware around the affected hip
  • Infection around the affected hip
  • Transfer patients with a length of stay > 24 hours at the transferring hospital
  • Known allergy to acetaminophen
  • Current use of narcotics
  • Receiving a regional anesthetic block at any point during the hospitalization
  • Known history of hepatic disease (hepatitis, cirrhosis)
  • Weight < 50kg
  • Involved in another clinical trial that would interfere with the intervention of this study

研究组 & 干预措施

IV Acetaminophen

Experimental

1,000mg Acetaminophen IV every 8 hours until the patient has received 3 doses post-operatively. Then 1,000mg Acetaminophen po every 8 hours until discharge.

干预措施: IV Acetaminophen (Drug)

PO Acetaminophen

Active Comparator

1,000mg Acetaminophen po every 8 hours until discharge.

干预措施: PO Acetaminophen (Drug)

结局指标

主要结局

Pain Score

时间窗: 6 days

Pain scores will be compared between the two groups.

次要结局

  • Timing of First Day of Ambulation.(6 days)
  • Distance Ambulated(6 days)
  • The Amount of Morphine Equivalents, as Determined by an Opioid Dose Calculator, Received by the Patient.(6 days)
  • Hospital Stay(2 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验